Opioid and alcohol use disorder medication availability in outpatient care: national estimates & potential policy levers.

ABSTRACT: Medications for opioid and alcohol use disorder (MOUD/MAUD) are efficacious, important components of relapse prevention care, and markedly underused. Yet, not all programs treating substance use disorders (SUD) offer them. Using the Substance Abuse and Mental Health Services Administration's 2022 National Substance Use and Mental Health Services Survey (N-SUMHSS), for outpatient programs (excluding opioid treatment programs) that provided "primarily SUD services" (SUD) or "primarily mental health but also SUD services" (MH/SUD; N = 9921 programs), we identified program characteristics associated with providing MOUD or MAUD, focusing on potential policy levers (state licensure/certification, national organization accreditation) that could increase MOUD/MAUD access. We found that only

SUBMITTER: Busch AB 

PROVIDER: S-EPMC11979098 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature